Literature DB >> 26095651

Soft tissue reconstruction after compound tibial fracture: 235 cases over 12 years.

Michael Wagels1, Dan Rowe2, Shireen Senewiratne2, Tavis Read2, David R Theile2.   

Abstract

BACKGROUND: Outcomes in management of compound tibial fractures are measured by the rate of infection and non-union. These are a function of many variables that interact in complex ways. Our aims are to describe changes in these injuries over the past decade, to determine which variables predict a poor outcome and to compare reconstructive options controlling for these variables.
METHODS: All compound tibial fractures reconstructed at the Princess Alexandra Hospital from 1999 to early 2009 were reviewed retrospectively. The remainder of 2009 and 2010 were reviewed prospectively. Data were collected from departmental audits, medical records and imaging.
RESULTS: 251 flaps were performed in 235 patients. Reconstructions within one week declined after 2000, which correlated with increasing Negative Pressure Dressings use (R = 0.77). Free flap use increased though the incidence of distal fractures did not (R = 0.29). Muscle flaps were consistently preferred. Injuries with a poor outcome had a greater delay or failed soft tissue reconstruction. A poor outcome was more likely in patients with a contaminated distal fracture (p = 0.0038). Outcomes in muscle and fasciocutaneous flaps were not significantly different.
CONCLUSIONS: Compound tibial fracture management has evolved to temporary followed by definitive fixation. Free flap use has increased, particularly in diaphyseal injuries. Delays in reconstruction should prompt aggressive surgical management. Injuries at risk of a poor outcome can be further characterised as being distal and contaminated. Reconstructive surgeons should not be discouraged from using muscle flaps. A management algorithm based on the evidence provided is presented. LEVEL OF EVIDENCE: Therapeutic III. Crown
Copyright © 2015. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Compound; Flap; Fracture; Leg; Reconstruction; Tibial

Mesh:

Year:  2015        PMID: 26095651     DOI: 10.1016/j.bjps.2015.05.017

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

1.  A preclinical large-animal model for the assessment of critical-size load-bearing bone defect reconstruction.

Authors:  David S Sparks; Siamak Saifzadeh; Flavia Medeiros Savi; Constantin E Dlaska; Arne Berner; Jan Henkel; Johannes C Reichert; Martin Wullschleger; Jiongyu Ren; Amaia Cipitria; Jacqui A McGovern; Roland Steck; Michael Wagels; Maria Ann Woodruff; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Nat Protoc       Date:  2020-02-14       Impact factor: 13.491

Review 2.  Pre-Clinical Evaluation of Biological Bone Substitute Materials for Application in Highly Loaded Skeletal Sites.

Authors:  Sónia de Lacerda Schickert; Jeroen J J P van den Beucken; Sander C G Leeuwenburgh; John A Jansen
Journal:  Biomolecules       Date:  2020-06-09

3.  Single-stage "Fix and Flap" gives Good Outcomes in Grade 3B/C Open Tibial Fractures: A Prospective Study.

Authors:  J Singh; M S Dhillon; S S Dhatt
Journal:  Malays Orthop J       Date:  2020-03

4.  Efficacy of a "provisional incision" for longitudinal flap division after free-flap surgery.

Authors:  Y Izawa; H Murakami; T Shirakawa; M Nishida; K Futamura; Y Kobayashi; Y Tsuchida
Journal:  JPRAS Open       Date:  2022-07-30

5.  Microsurgical Reconstruction in an Orthopedic Hospital: Indications and Outcomes in Adults.

Authors:  Raquel Bernardelli Iamaguchi; Lucas Sousa Macedo; Alvaro Baik Cho; Marcelo Rosa de Rezende; Rames Mattar; Teng Hsiang Wei
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2022-03-11

6.  Identification of ultrasound imaging markers to quantify long bone regeneration in a segmental tibial defect sheep model in vivo.

Authors:  Songyuan Tang; Peer Shajudeen; Ennio Tasciotti; Raffaella Righetti
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.